One of the biggest public health stories of 2023 was the approval and subsequent rollout of the world’s first RSV vaccines for seniors and infants, an achievement that scientists had been working toward for decades. Immunologist and virologist Barney Graham was among the researchers whose work led to the development of the RSV vaccines by identifying and targeting the F protein found on the surface of the virus. It’s been an impactful few years for Graham, who was also instrumental in developing the spike protein target used in a number of Covid vaccines.
Barney S. Graham
Professor of medicine and microbiology, biochemistry, and immunology; director of the David Satcher Global Health Equity Institute, Morehouse School of Medicine
More in Academia
Academia
David Baker
Professor, biochemistry, University of Washington
Academia
Ruha Benjamin
Alexander Stewart 1886 Professor of African American Studies, Princeton University
Academia
Elisabeth Bik
Science integrity consultant
Academia
Emmanuelle Charpentier
Scientific and managing director, Max Planck Unit for the Science of Pathogens
Academia
Rory Cooper
Director, Human Engineering Research Labs, University of Pittsburgh and U.S. VA Department
Academia
Diana Greene Foster
Professor of obstetrics, gynecology, and reproductive sciences, UCSF
Academia
Judy Gichoya
Associate professor of interventional radiology and informatics, Emory University
Academia
Jacob Hanna
Professor of stem cell biology and synthetic embryology, Weizmann Institute of Science
Academia
Monica McLemore
Interim director, Manning Price Spratlen Center for Anti-Racism and Equity, U. of Washington
Academia
Dariush Mozaffarian
Director, Food Is Medicine Institute, Tufts University
Academia
Ida Sim
Professor and chief research informatics officer, UCSF
Academia
Feng Zhang
Core member, Broad Institute of MIT and Harvard
Fifty influential people shaping the future of health and life sciences across biotech, medicine, health care, policy, and health tech
View the List